Gotham Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $52.3M | Buy |
862,207
+79,339
| +10% | +$4.63M | 0.16% | 91 |
|
|
2025
Q4 | $42.2M | Buy |
782,868
+84,644
| +12% | +$4.07M | 0.15% | 100 |
|
|
2025
Q3 | $31.5M | Buy |
698,224
+90,238
| +15% | +$4.21M | 0.14% | 151 |
|
|
2025
Q2 | $28.1M | Buy |
607,986
+311,033
| +105% | +$15.3M | 0.17% | 86 |
|
|
2025
Q1 | $18.1M | Buy |
296,953
+21,411
| +8% | +$1.25M | 0.15% | 140 |
|
|
2024
Q4 | $15.6M | Sell |
275,542
-61,467
| -18% | -$3.43M | 0.15% | 155 |
|
|
2024
Q3 | $17.4M | Buy |
337,009
+50,171
| +17% | +$2.35M | 0.18% | 88 |
|
|
2024
Q2 | $11.9M | Sell |
286,838
-59,372
| -17% | -$2.66M | 0.15% | 124 |
|
|
2024
Q1 | $18.8M | Buy |
346,210
+87,060
| +34% | +$4.43M | 0.28% | 33 |
|
|
2023
Q4 | $13.3M | Buy |
259,150
+51,745
| +25% | +$2.72M | 0.25% | 47 |
|
|
2023
Q3 | $12M | Buy |
207,405
+52,110
| +34% | +$3.19M | 0.25% | 46 |
|
|
2023
Q2 | $9.93M | Buy |
155,295
+63,449
| +69% | +$4.25M | 0.22% | 66 |
|
|
2023
Q1 | $6.37M | Sell |
91,846
-92,512
| -50% | -$6.53M | 0.15% | 138 |
|
|
2022
Q4 | $13.3M | Buy |
184,358
+12,972
| +8% | +$978K | 0.37% | 28 |
|
|
2022
Q3 | $12.2M | Buy |
171,386
+45,754
| +36% | +$3.32M | 0.36% | 27 |
|
|
2022
Q2 | $9.67M | Buy |
125,632
+18,383
| +17% | +$1.4M | 0.31% | 54 |
|
|
2022
Q1 | $7.83M | Buy |
107,249
+7,088
| +7% | +$476K | 0.24% | 89 |
|
|
2021
Q4 | $6.25M | Buy |
100,161
+5,381
| +6% | +$316K | 0.2% | 115 |
|
|
2021
Q3 | $5.61M | Buy |
94,780
+90,217
| +1,977% | +$5.94M | 0.23% | 121 |
|
|
2021
Q2 | $305K | Buy |
+4,563
| New | +$298K | 0.01% | 839 |
|
|
2021
Q1 | – | Sell |
-66,597
| Closed | -$4.13M | – | 990 |
|
|
2020
Q4 | $4.13M | Sell |
66,597
-74,004
| -53% | -$4.55M | 0.14% | 219 |
|
|
2020
Q3 | $8.48M | Sell |
140,601
-219,426
| -61% | -$13.2M | 0.27% | 105 |
|
|
2020
Q2 | $21.2M | Buy |
360,027
+94,928
| +36% | +$5.68M | 0.63% | 17 |
|
|
2020
Q1 | $14.8M | Sell |
265,099
-699,364
| -73% | -$42.7M | 0.41% | 54 |
|
|
2019
Q4 | $61.9M | Sell |
964,463
-60,747
| -6% | -$3.48M | 1.14% | 2 |
|
|
2019
Q3 | $52M | Sell |
1,025,210
-235,538
| -19% | -$11.1M | 0.92% | 9 |
|
|
2019
Q2 | $57.2M | Buy |
1,260,748
+340,589
| +37% | +$15.9M | 0.91% | 6 |
|
|
2019
Q1 | $43.9M | Buy |
920,159
+679,164
| +282% | +$33.8M | 0.64% | 16 |
|
|
2018
Q4 | $12.5M | Buy |
240,995
+45,990
| +24% | +$2.47M | 0.19% | 161 |
|
|
2018
Q3 | $12.1M | Sell |
195,005
-101,296
| -34% | -$6.01M | 0.17% | 187 |
|
|
2018
Q2 | $16.4M | Buy |
296,301
+273,224
| +1,184% | +$14.8M | 0.24% | 131 |
|
|
2018
Q1 | $1.46M | Sell |
23,077
-131,716
| -85% | -$8.47M | 0.02% | 550 |
|
|
2017
Q4 | $9.49M | Buy |
154,793
+33,199
| +27% | +$2.08M | 0.14% | 222 |
|
|
2017
Q3 | $7.75M | Buy |
121,594
+34,135
| +39% | +$1.99M | 0.11% | 284 |
|
|
2017
Q2 | $4.87M | Buy |
87,459
+77,398
| +769% | +$4.21M | 0.07% | 365 |
|
|
2017
Q1 | $547K | Buy |
+10,061
| New | +$552K | 0.01% | 749 |
|
|
2016
Q4 | – | Sell |
-87,321
| Closed | -$4.71M | – | 948 |
|
|
2016
Q3 | $4.71M | Buy |
+87,321
| New | +$5.61M | 0.06% | 364 |
|
|
2015
Q4 | – | Sell |
-21,863
| Closed | -$1.29M | – | 873 |
|
|
2015
Q3 | $1.29M | Buy |
+21,863
| New | +$1.39M | 0.01% | 586 |
|
|
2014
Q3 | – | Sell |
-89,363
| Closed | -$4.33M | – | 989 |
|
|
2014
Q2 | $4.33M | Buy |
+89,363
| New | +$4.4M | 0.05% | 423 |
|
|
2014
Q1 | – | Sell |
-11,679
| Closed | -$621K | – | 1007 |
|
|
2013
Q4 | $621K | Buy |
+11,679
| New | +$595K | 0.01% | 713 |
|
Other funds holding BMY
VCM
VPM
Gotham Asset Management's BMY Position: Q1 2026 in Review
Gotham Asset Management increased its Bristol-Myers Squibb (BMY) stake by 10% in Q1 2026, buying an estimated $4.63M and bringing the position to 862,207 shares worth $52.3M. The position accounts for 0.16% of the portfolio, ranked #91.
Gotham Asset Management first reported a position in BMY in Q4 2013 and has held it in 40 quarters since. The position peaked at $61.9M in Q4 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Gotham Asset Management held 862,207 shares of Bristol-Myers Squibb worth $52.3M as of Q1 2026.
- Gotham Asset Management bought 79,339 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.63M.
- Bristol-Myers Squibb made up 0.16% of Gotham Asset Management's portfolio in Q1 2026, its #91 holding.
- Gotham Asset Management first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 40 quarters since.
- Gotham Asset Management's Bristol-Myers Squibb position peaked at $61.9M in Q4 2019.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.